Genmab A (GMAB) Cash & Current Investments (2023 - 2025)

Genmab A's Cash & Current Investments history spans 3 years, with the latest figure at $1.7 billion for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 24.28% year-over-year to $1.7 billion; the TTM value through Dec 2025 reached $1.7 billion, up 24.28%, while the annual FY2025 figure was $1.7 billion, 24.28% up from the prior year.
  • Cash & Current Investments reached $1.7 billion in Q4 2025 per GMAB's latest filing, up from $1.4 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $2.2 billion in Q4 2023 to a low of $1.4 billion in Q4 2024.
  • Average Cash & Current Investments over 3 years is $1.8 billion, with a median of $1.7 billion recorded in 2025.
  • Peak YoY movement for Cash & Current Investments: tumbled 37.39% in 2024, then rose 24.28% in 2025.
  • A 3-year view of Cash & Current Investments shows it stood at $2.2 billion in 2023, then plummeted by 37.39% to $1.4 billion in 2024, then grew by 24.28% to $1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for GMAB's Cash & Current Investments are $1.7 billion (Q4 2025), $1.4 billion (Q4 2024), and $2.2 billion (Q4 2023).